Non-Alcoholic Steatohepatitis (NASH) Clinical Trials

The voice of NASH investigators

Global survey provides insights for trial operations

Non-alcoholic steatohepatitis (NASH), a component of metabolic syndrome, is an area of very active clinical development. With no approved therapies to treat NASH, there are more than 130 Phase II or Phase III NASH trials underway or planned.

To help determine the impact of this competitive environment for available and qualified site resources, as well as eligible patients, ICON undertook a global survey of NASH clinical trial sites across 37 different countries.

Read the whitepaper

Digital solutions to alleviate NASH clinical trial challenges

The performance of NASH clinical trials presents many challenges unique to the field. Watch the on-demand webinar to learn about:

The ability for digital technologies MRI, MRE and whole slide imaging to address NASH clinical trial challenges
The ability of MRI and MRE to provide timely, high quality non-invasive solutions to enrolment
The ability of whole slide imaging to facilitate rapid complex workflows that assure consistent high quality assessments of primary efficacy endpoints by enabling expert histopathologists to interact remotely and in real time.

Access the webinar recording

Helping NASH study sites to succeed

Get insights and feedback from our extensive NASH study experience, and the findings from ICON’s survey of more than 2,000 sites across 30 countries including:

How to best support global NASH sites to succeed in a competitive environment
Optimising the operational strength of study sites to collectively support the NASH pipeline
How understanding global and regional nuances can enhance NASH site patient recruitment and operational strategy

Access the webinar recording

Join Andrew Roche, PhD, a senior member of ICON's NASH team, as he speaks about overcoming the challenges and considerations associated with NASH Clinical Trials and examination of potential strategies to address during trial design or study execution.

Access the webinar recording